The rest of the 100: Dan Sheehan, managing director at Covidien Ventures
Dan Sheehan has managed the activities of Covidien Ventures since the corporate venturing unit of the US-based healthcare provider was founded in 2008. The corporate venturing programme invests up to $5m per round and followed Covidien’s spin-out from conglomerate Tyco International in June 2007 to expand into medical devices.
Sheehan’s background includes both venture capital investing and management roles in the healthcare sector, including general partner with Affinity Capital Management, a healthcare-oriented venture capital firm in Minneapolis. He has also managed the business development and strategic marketing efforts for Steris Corporation, a provider of infection prevention and surgical support products for the healthcare and life sciences sectors.
He has been a director of many portfolio companies and is a graduate of Fordham University and Columbia Business School.
